TITAN PHARMACEUTICALS INC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
TITAN PHARMACEUTICALS INC has filed 1,052 SEC EDGAR filings since 15 May 1996

SEC filing history

Showing 1-14 of 14 matching filings.

Per page
25
Current page
1
SC 13D/A File 005-46083

SC 13D/A

Filing date
21 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-46083

SC 13D/A

Filing date
05 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-46083

SC 13D

Filing date
04 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-46083

SC 13D filing

Filing date
21 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-46083

AMENDMENT NO. 5 TO THE SCHEDULE 13D

Filing date
23 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-46083

AMENDMENT NO. 4 TO THE SCHEDULE 13D

Filing date
15 Dec 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-46083

AMENDMENT NO. 3 TO THE SCHEDULE 13D

Filing date
17 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-46083

AMENDMENT NO. 2 TO THE SCHEDULE 13D

Filing date
08 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-46083

AMENDMENT NO. 1 TO THE SCHEDULE 13D

Filing date
09 Jun 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-46083

THE SCHEDULE 13D

Filing date
25 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-46083

SCHEDULE 13D - AMEND. 3

Filing date
28 Jun 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-46083

SCHEDULE 13D - AMEND. 2

Filing date
03 Jun 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-46083

TITAN PHARMACEUTICALS, INC.-AMEND. #1

Filing date
12 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-46083

SCHEDULE 13D

Filing date
04 Dec 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .